Pharvaris N.V.

Contributing Author

Recent Articles by Pharvaris N.V.

Jun-27	Pharvaris Announces Clinical Trial Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2025 US HAEA National Summit PHVS GlobeNewswire
Jun-16	Pharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat Bradykinin-Mediated Angioedema Attacks at the EAACI Congress PHVS GlobeNewswire
Jun-10	Pharvaris Announces Annual Meeting of Shareholders PHVS GlobeNewswire
Jun-02	Pharvaris Presents Data Supporting Ongoing Clinical Development of Deucrictibant in Bradykinin-Mediated Angioedema PHVS GlobeNewswire
May-19	Pharvaris to Present Deucrictibant Clinical Data and Exploratory Biomarker Data at Upcoming Congresses PHVS GlobeNewswire
May-13	Pharvaris Reports First Quarter 2025 Financial Results and Provides Business Update PHVS GlobeNewswire
May-12	Pharvaris to Host a Virtual R&D Call "Deucrictibant: Beyond HAE Type 1/2" on June 4 PHVS GlobeNewswire